COMPANY
SANOFI-AVENTIS CANADA INC
SANOFI-AVENTIS CANADA INC: marketing authorisation holder for Calcitonin, Lixisenatide, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Calcitonin | CALCIMAR (DIN 01926691), Cancelled Post Market Regulator Health Canada |
|---|---|
| Lixisenatide | ADLYXINE (DIN 02464276), Cancelled Post Market Regulator Health Canada |
| Lixisenatide | ADLYXINE (DIN 02464284), Cancelled Post Market Regulator Health Canada |
| Lixisenatide | ADLYXINE (DIN 02464349), Cancelled Post Market Regulator Health Canada |
| Lixisenatide | SOLIQUA (DIN 02478293), Marketed Regulator Health Canada |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.